Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference6 articles.
1. ABECMA® (idecabtagene vicleucel) [package insert]. Summit, NJ: Celgene Corporation, a Bristol Myers Squibb Company; 2021.
2. CARVYKTI™ (ciltacabtagene autoleucel) [package insert]. Horsham, PA: Janssen Biotech, Inc.; 2022.
3. Al Hadidi S, Szabo A, Esselmann J, et al. Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy [e-pub ahead of print]. Bone Marrow Transplant. https://doi.org/10.1038/s41409-022-01905-1, Accessed February 14 2023.
4. Principles for allocation of scarce medical interventions;Persad;Lancet,2009
5. Fair allocation of scarce medical resources in the time of Covid-19;Emanuel;N Engl J Med,2020
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献